I før- NNRTI- stratummet var responsraten 98, 9% versus 97, 4% for henholdsvis Atripla - og SBR- patienterne; en forskel (95% CI) på 1, 4% (- 4, 0%; 6, 9%).
In the prior-NNRTI stratum, response rates were 98.9% vs 97.4% for Atripla and SBR patients respectively; a difference (95%CI) of 1.4% (-4.0%, 6.9%).